Antiretroviral combination therapy for HIV infection.
Since the introduction of highly active antiretroviral therapy, studies have demonstrated declining morbidity and mortality rates among people with HIV. This is largely because antiretroviral combination therapy can suppress plasma HIV viral load below detectable limits and cause gradual elevation in CD4 cell counts, resulting in improved immune status for responsive patients who are compliant with therapy. These drugs, however, are not without side-effects, both general and oral, and this review draws attention to some of the interactions of the drugs used to treat HIV infection with drugs used in dentistry.
Lewis
Debbie A
DA
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D024882:Drug Resistance, Viral; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D011480:Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use
D019380:Anti-HIV Agents; D011480:Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors